These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16671331)

  • 1. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
    Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
    Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.
    Takami T
    Hypertens Res; 2009 Dec; 32(12):1086-90. PubMed ID: 19779491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R; Zoppi A; Derosa G; Mugellini A; Lazzari P; Rinaldi A; Fogari E; Preti P
    J Hum Hypertens; 2007 Mar; 21(3):220-4. PubMed ID: 17215848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
    Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness.
    Matsui Y; Kario K; Ishikawa J; Hoshide S; Eguchi K; Shimada K
    Hypertens Res; 2005 Aug; 28(8):631-8. PubMed ID: 16392766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension.
    Kurata M; Okura T; Irita J; Enomoto D; Nagao T; Jotoku M; Miyoshi K; Desilva VR; Higaki J
    J Hum Hypertens; 2011 May; 25(5):334-9. PubMed ID: 20664555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
    Ke YS; Tao YY; Yang H; Yu GH
    Acta Pharmacol Sin; 2003 Apr; 24(4):337-41. PubMed ID: 12676074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering.
    Kita T; Suzuki Y; Eto T; Kitamura K
    Hypertens Res; 2005 Dec; 28(12):959-64. PubMed ID: 16671334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists supplementation is associated with arterial stiffness: insight from a retrospective study in 116 peritoneal dialysis patients.
    Huang WH; Hsu CW; Chen YC; Hung CC; Huang JY; Lin JL; Yang CW
    Ren Fail; 2007; 29(7):843-8. PubMed ID: 17994453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive indices of arterial stiffness in hemodialysis patients.
    Ueyama K; Miyata M; Kubozono T; Nagaki A; Hamasaki S; Ueyama S; Tei C
    Hypertens Res; 2009 Aug; 32(8):716-20. PubMed ID: 19521417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.